CSS LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

CSS LLC’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,000	Closed	-$740K	–	630
2019 Q4	$740K	Buy	+2,000	New	+$705K	0.04%	295

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

CSS LLC's BIO Position: Q2 2020 in Review

CSS LLC sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2020, closing a stake of 300 shares — an estimated $105K sold.

CSS LLC first reported a position in BIO in Q1 2020 and held it in 1 quarter. The position peaked at $105K in Q1 2020. 470 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

CSS LLC reported no remaining Bio-Rad Laboratories Class A position as of Q2 2020 after selling out during the quarter.
CSS LLC sold 300 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $105K.
CSS LLC first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and held it in 1 quarter.
CSS LLC's Bio-Rad Laboratories Class A position peaked at $105K in Q1 2020.
470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on CSS LLC's 13F filing for Q2 2020, filed 14 Aug 2020.